Air-test as a Predictor of Pulmonary and Systemic Complications After Laparoscopic Surgery
1 other identifier
observational
250
1 country
1
Brief Summary
One of the main risk factors for the development of postoperative pulmonary complications (PPC) in postsurgical patients is the persistence of atelectasis during this period. Therefore, it would be of great clinical interest to establish a causal relationship between postoperative atelectasis and the development of PPC, as well as having a relatively precise, simple and non-invasive method to rapidly diagnose these atelectasis. A prospective observational study will be carried out including all patients undergoing scheduled laparoscopic surgery, excluding pregnant women or women in the period of lactation, patients with moderate - severe acute respiratory distress syndrome, heart failure, need for mechanical ventilation during the 15 days prior to surgery or with a history of cardiothoracic surgery. Demographic variables (age, sex, weight, BMI), preoperative data (presence of allergies, cardiovascular risk factors, personal cardiopulmonary history, presence of toxic habits, baseline peripheral oxygen saturation, ASA classification, ARISCAT and frailty markers will be collected - Fried phenotype, scale clinical frailty and FRAIL scale -) and intraoperative (duration of the procedure, recruitment maneuvers). At 30 postoperative days the history will be reviewed clinic of the patients and the postoperative complications will be collected. Main objective: to demonstrate the veracity of the air-test in the prevention of pulmonary or other systemic complications in patients undergoing laparoscopic surgery. Secondary objectives:
- Measure the incidence of positive results in the air-test.
- Demonstrate the correlation between the performance of recruitment maneuvers and a negative score in the air-test
- Demonstrate the correlation between the degree of frailty of the patients and a positive score in the air-test.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 17, 2021
CompletedFirst Posted
Study publicly available on registry
May 20, 2021
CompletedStudy Start
First participant enrolled
June 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2024
CompletedJuly 24, 2024
July 1, 2024
3.1 years
May 17, 2021
July 23, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Postoperative pulmonary complications
to demonstrate the veracity of the air-test in the prevention of pulmonary complications in patients undergoing scheduled laparoscopic surgery
30 days postoperatively
Postoperative systemic complications
to demonstrate the veracity of the air-test in the prevention of systemic complications in patients undergoing scheduled laparoscopic surgery
30 days postoperatively
Secondary Outcomes (2)
Incidence of positive air-test
4 hours postoperatively
Recruitment maneuvers and air-test
from the intraoperative period (recruitment maneuvers) until 4 hours postoperatively
Eligibility Criteria
Patients undergoing scheduled laparoscopic surgery will be included and informed consent will be asked to perform air-test postoperatively.
You may qualify if:
- patients undergoing scheduled laparoscopic surgery
You may not qualify if:
- Pregnant or lactating women.
- Presence of moderate to severe acute respiratory distress.
- Patients suffering from heart failure.
- Patients undergoing invasive mechanical ventilation during the 15 days prior to surgery.
- Patients with a history of cardiothoracic surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ángel Becerra
Las Palmas de Gran Canaria, Las Palmas, 35019, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ángel Ángel, MD
Hospital Universitario de Gran Canaria Doctor Negrín
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 17, 2021
First Posted
May 20, 2021
Study Start
June 1, 2021
Primary Completion
June 30, 2024
Study Completion
June 30, 2024
Last Updated
July 24, 2024
Record last verified: 2024-07